SHC Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - Sotera Health Co - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 11.27 USD 0.63%

Updated:

Section:

Wall Street
Price Targets

Wall Street analysts forecast SHC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SHC is 17.24 USD with a low forecast of 14.14 USD and a high forecast of 21 USD.

SHC Lowest Forecast

Wall Street Target

SHC Average Forecast

Wall Street Target

SHC Highest Forecast

Wall Street Target

25% Upside

53% Upside

86% Upside

The latest public price target was made on Apr 10, 2024 by Luke Sergott from Barclays , who expects SHC stock to rise by 24% over the next 12 months. You can read more about this price target by viewing the article on TheFly.

Analyst	Price Target	Date	Article
Luke Sergott Barclays	14 USD Upside 24%	3 weeks ago Apr 10, 2024	Sotera Health price target lowered to $14 from $19 at Barclays TheFly
David Windley Jefferies	15.5 USD Upside 38%	1 month ago Mar 25, 2024	Jefferies Upgrades Sotera Health (SHC) to Buy StreetInsider
Matthew Mishan Loop Capital Markets	24 USD Upside 113%	10 months ago Jun 26, 2023	Analyst Upgrades Sotera Health Shares To Overweight, Cites Strong Revenue Growth Outlook Benzinga

Price Target	14 USD
Upside/Downside	24%

Price Target	15.5 USD
Upside/Downside	38%

Price Target	24 USD
Upside/Downside	113%

Abnova Taiwan Corp

226% Upside

Azenta Inc

36% Upside

Repligen Corp

32% Upside

Proteomics International Laboratories Ltd

35% Upside

Abnova Taiwan Corp

226% Upside

Azenta Inc

36% Upside

Repligen Corp

32% Upside

Proteomics International Laboratories Ltd

35% Upside

Brooks Laboratories Ltd

49% Downside

SKAN Group AG

14% Upside

MGI Tech Co Ltd

69% Upside

Fortrea Holdings Inc

11% Upside

Revenue
Forecast

For the last 4 years the compound annual growth rate for Sotera Health Co's revenue is 8%. The projected CAGR for the next 3 years is 7%.

8%

7%

-1%

What are analyst estimates?

Operating Income
Forecast

For the last 4 years the compound annual growth rate for Sotera Health Co's operating income is 10%. The projected CAGR for the next 3 years is 27%.

10%

27%

-38%

What are analyst estimates?

Net Income
Forecast

The compound annual growth rate of Sotera Health Co's net income for the next 3 years is 78%.

N/A

78%

N/A

What are analyst estimates?

See Also

Relative Valuation

Wall Street Estimates

Profitability Analysis

Solvency Analysis

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

According to Wall Street analysts, the average 1-year price target for SHC is 17.24 USD with a low forecast of 14.14 USD and a high forecast of 21 USD.

For the last 4 years the compound annual growth rate for Sotera Health Co's revenue is 8%. The projected CAGR for the next 3 years is 7%.

For the last 4 years the compound annual growth rate for Sotera Health Co's operating income is 10%. The projected CAGR for the next 3 years is 27%.

The compound annual growth rate of Sotera Health Co's net income for the next 3 years is 78%.

Join more than 133,400+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.